Newsroom

Sorted by: Latest

-

Source Support Services Unveils the Unified Services Platform

LAWRENCEVILLE, Ga.--(BUSINESS WIRE)--Source Support Services launches its Unified Services Platform to orchestrate service outcomes at scale across the global data center economy....
-

McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK), a leading Healthcare Services company, today announced it has entered into a definitive agreement with funds managed by affiliates of Apollo (“Apollo Funds”), under which Apollo Funds will acquire a minority ownership interest in McKesson’s Medical-Surgical Solutions (“MMS”) business. This transaction represents a meaningful milestone as McKesson executes its separation strategy of MMS in preparation of a planned initial public o...
-

Fairbanks Morse Defense’s All-Electric Davit by Welin Lambie Achieves First Article Test Milestone for US Coast Guard Offshore Patrol Cutter Program

BELOIT, Wis.--(BUSINESS WIRE)--Welin Lambie, a Fairbanks Morse Defense (FMD) company, today announced its TWPIV 5.0E all-electric, dual-point davit system successfully completed the First Article Test milestone for the U.S. Coast Guard’s (USCG) Offshore Patrol Cutter (OPC) Stage 2 program. The milestone confirms the system satisfies OPC Stage 2 requirements for safely launching and recovering small boats in demanding maritime conditions, with the TWPIV 5.0E designed to deliver high availability...
-

INBRAIN Neuroelectronics Completes Enrolment of World’s First-in-Human Study of Graphene Neural Interfaces for Brain Decoding & Mapping

BARCELONA, Spain--(BUSINESS WIRE)--INBRAIN Neuroelectronics Completes Enrolment of World’s First-in-Human Study of Graphene Neural Interfaces for Brain Decoding & Mapping...
-

LightSpun Names Healthcare Growth Veteran Bill Henderson as Strategic Advisor to the CEO, Accelerating National Expansion

BOSTON--(BUSINESS WIRE)--LightSpun names Bill Henderson as Strategic Advisor to the CEO...
-

Takara Bio USA, Inc. Validates New Class of Spatial Technology with Benchmark Study for Cancer Research

SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA, Inc. today announced a benchmark study comparing the performance of its Trekker® FX technology against conventional spatial methods....
-

Farmers & Merchants Bank of Long Beach Reports 2026 First Quarter Results

LONG BEACH, Calif.--(BUSINESS WIRE)--Farmers & Merchants Bank of Long Beach (“F&M” or the “Bank”) (OTCQX: FMBL) today reported financial results for the first quarter ended March 31, 2026. “F&M recorded another outstanding quarter, with improvements achieved in all measures of operating performance, compared with the comparable prior year period,” said W. Henry Walker, Chief Executive Officer. “Our balance sheet remained strong at quarter end, and F&M’s capital ratios again exce...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 17.04.2026 MDEC.LN IE0007FIJUO5 50,002.00 USD 1,389,692.19 27.793  ...
-

Vizient Showcases Integrated Supply Chain Capabilities at Spring IDN to Strengthen Trust in Healthcare Performance

IRVING, Texas--(BUSINESS WIRE)--These Vizient capabilities connect insight to execution while reinforcing consistency, accountability and performance across the supply chain....
-

Palleon Pharmaceuticals Presents First-in-Class B7-H3 Targeted Sialidase at the 2026 AACR Annual Meeting

WALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals today presented preclinical data and announced the initiation of a human clinical trial for E-688/HLX316, a first-in-class B7-H3 targeted sialidase, in an oral presentation at the American Association for Cancer Research (AACR) Annual Meeting “New Drugs on the Horizon” session. The presentation, titled “E-688/HLX316: A First-in-Class B7-H3 Targeted Sialidase for Boosting Innate and Adaptive Anti-Tumor Immunity” introduces the first ever t...